Status
Conditions
Treatments
About
A diagnostic and prognostic study, in which the expression of CD64 in activated neutrophils and CD64 and IL17A regulatory T cells in patients with sepsis will be evaluated as a probable marker for sepsis as a primary objective
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
60 participants in 2 patient groups
Loading...
Central trial contact
Walaa Y Elsabeeny, MD; Ahmed Samir, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal